Location History:
- Bolligen, CH (1994)
- Neuenegg, CH (2003)
Company Filing History:
Years Active: 1994-2003
Title: **Stanley J. Cryz: Innovator in Vaccine Development**
Introduction
Stanley J. Cryz, located in Neuenegg, Switzerland, is a renowned inventor known for his significant contributions to the field of vaccine development. With a total of two patents to his name, Cryz's work focuses primarily on innovative methods for producing live vaccines against gram-negative pathogens.
Latest Patents
Cryz's latest patents showcase his pioneering work in vaccine technology. One of his notable inventions is related to live vaccines against gram-negative pathogens, which utilize genetically modified live attenuated vaccine carrier strains. These strains are designed to express heterologous O-antigens, facilitating efficient immunization against gram-negative enteric pathogens. His other significant patent involves the production of an Escherichia coli O-polysaccharide-protein conjugate vaccine. This vaccine production method purifies lipopolysaccharide from E. coli and involves covalently coupling lipid A-free O-polysaccharide to a carrier protein, thus establishing a pathway for the development of polyvalent vaccines.
Career Highlights
Stanley J. Cryz works at the Swiss Serum and Vaccine Institute Berne, where he contributes his expertise in vaccine research and development. His work has been critical in advancing the field of immunization, particularly in creating effective vaccines against challenging pathogens.
Collaborations
Throughout his career, Cryz has collaborated with several esteemed colleagues, including Emil P. Furer and Didier Favre. These collaborations have fostered innovative ideas and solutions in the realm of vaccine technology, enhancing the efficacy of immunological approaches.
Conclusion
In summary, Stanley J. Cryz is an influential inventor recognized for his groundbreaking work in vaccine development. His patents reflect a commitment to improving public health through innovative immunization strategies. With a strong foundation in scientific research and collaboration, Cryz continues to make significant strides in vaccine technology.